default author photo

Laurence Venat

Hôpital Universitaire Dupuytren

SCHOLARLY PAPERS

2

DOWNLOADS

169

TOTAL CITATIONS

0

Scholarly Papers (2)

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the UCBG- UNIRAD Trial

Number of pages: 39 Posted: 27 Mar 2025
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, Université Paris Saclay and Hopital Saint-Louis
Downloads 102 (684,532)

Abstract:

Loading...

breast cancer, endocrine therapy, everolimus, circadian rhythm, intake timing

Association between Daily Timing of Everolimus Combined with Adjuvant Endocrine Therapy with Survival Outcomes in Patients with High-Risk Hormone Positive and Her2 Negative Early Breast Cancer: Results of a Sub-Study of the Ucbg- Unirad Trial

Number of pages: 39 Posted: 17 Apr 2025
PSL Research University - Institut Curie, Institut Curie - Department of Medical Oncology, University of Claude Bernard Lyon 1 - Medical Oncology Department, Sorbonne University - Hôpital Pitié-Salpêtrière, UNICANCER, Gustave Roussy - Breast Cancer Unit, University of Edinburgh - Edinburgh Cancer Centre, Institute of Cancer Research (ICR) - Clinical Trials and Statistics Unit (ICR-CTSU), University of Claude Bernard Lyon 1 - Department of Clinical Research Centre, Armorican Center for Radiotherapy, Medical Imaging, and Oncology (CARIO), University of Paris-Saclay - Institut Gustave Roussy, Centre François Baclesse, University of Bordeaux - Institut Bergonié, Institut de Cancerologie de l’Ouest, Hôpital Universitaire Dupuytren, École Normale Supérieure - PSL Research University - Institut Curie, Clinique Pasteur, Sainte Catherine Institute, Institut Claudius Regaud - IUCT-Oncopole, CRCT, Inserm, Université Paris Cité, PSL Research University - Institut Curie, UNICANCER, Centre Jean Perrin, University of Warwick - Cancer Chronotherapy Team and Hopital Saint-Louis
Downloads 33 (1,385,838)

Abstract:

Loading...

Breast cancer, endocrine therapy, everolimus, Circadian rhythm, intake timing

2.

Association and Performance of Polygenic Risk Scores for Breast Cancer Among French Women Presenting or Not a Familial Predisposition to the Disease

Number of pages: 18 Posted: 08 Sep 2022
INSERM, U900, University of Paris-Saclay, INSERM, U900, INSERM, U900, Paris Dauphine University - PSL Research University, INSERM, U900, University of Paris-Saclay, INSERM, U900, INSERM, U900, University of Paris-Saclay, University of Paris-Saclay, University of Paris-Saclay, University of Paris-Saclay, Centre Georges-François Leclerc, CHU de Brest, Centre François Baclesse, Claude Bernard Lyon 1 University, Paris Dauphine University - PSL Research University, Gustave Roussy, Université Clermont Auvergne, University Hospital Caremeau, Paris Dauphine University - PSL Research University, CHU Hôpital Saint-Jacques, CHU de Montpellier - Arnaud de Villeneuve Hospital, Institut de Cancérologie de l'Ouest, Paris Dauphine University - PSL Research University, Grenoble Alpes University Hospital, Centre Hospitalier de Chambéry, Paris Dauphine University - PSL Research University, CH Georges Renon, Hospices Civils de Lyon, Institut Claudius Regaud, Paris Dauphine University - PSL Research University, Claude Bernard Lyon 1 University, University of Lille - CHU Lille, Hospices Civils de Lyon, Université Cote d'Azur - Hôpital Pasteur, Hôpital Privé du Confluent, Hôpital de Mercy, Centre Antoine Lacassagne, University of Strasbourg - Hôpitaux Universitaires de Strasbourg, François Rabelais University - CHU Bretonneau - CHU Hôpitaux De Tours, Paris Dauphine University - PSL Research University, Centre Georges-François Leclerc, Institut Paoli-Calmettes, Institut Paoli-Calmettes, CHU Saint-Etienne, University of Paris-Saclay, Bergonié Institute, Institut Paoli-Calmettes, Institut Claudius Regaud, CHU Clermont-Ferrand, Centre François Baclesse, Hôpital Universitaire Dupuytren, University of Paris-Saclay, University of Paris-Saclay - INSERM, CESP, Centre National de Recherche en Génomique Humaine, Institut Curie, INSERM, U900 and INSERM, U900
Downloads 34 (1,263,436)

Abstract:

Loading...

breast cancer, genetic susceptibility, BRCA1, BRCA2, SNP, Polygenic risk score, risk prediction